Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in XGN — Exagen Inc.

CIK 1390777 NEW YORK, NY
Back to XGN Full portfolio

Position in XGN

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$97,360
+$34,546 QoQ
Shares Held
20,938
0.0% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 57 holders
Holding Since
Jun 2020
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $6,393,808,678 across 32 Diagnostics & Research names. XGN ranks #31 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 3,938,410 $1,974,561,224
2 MTD
Mettler Toledo International Inc/
 596,906 $762,553,373
3 DHR
Danaher Corp /De/
 3,742,518 $712,874,818
4 A
Agilent Technologies, Inc.
 5,233,964 $695,227,423
5 IDXX
Idexx Laboratories Inc /De
 1,193,343 $628,223,477
6 ILMN
Illumina, Inc.
 1,671,192 $293,845,680
7 WAT
Waters Corp /De/
 503,214 $188,725,368
8 IQV
Iqvia Holdings Inc.
 933,111 $180,295,698

All Filings in XGN

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $97,360 20,938
2026-03-31 $62,814 20,938
2025-12-31 $215,140 35,385
2025-09-30 $126,548 11,515
2022-03-31 $208,112 25,917
2021-12-31 $306,984 26,396
2021-09-30 $435,254 32,004
2021-06-30 $415,806 27,739
2021-03-31 $212,974 12,170
2020-12-31 $183,109 13,872
2020-09-30 $156,951 14,479
2020-06-30 $186,372 15,018